{
    "nctId": "NCT05241119",
    "briefTitle": "Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy",
    "officialTitle": "Precise Treatment of Axillary Lymph Nodes After Neoadjuvant Chemotherapy Guided by Long-term Nanocarbon Tracing: a Clinical Cohort Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "post-surgery pathology concordance rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* invasive breast cancer confirmed by biopsy and histology;\n* based on prone CT scan and Doppler ultrasound, axillary stage cN2-3;\n* agree and meet the requirements for NAC;\n* meet surgical requirements and agree to undergo surgery after NAC;\n* the regime of NAC follows the NCCN recommendations.\n\nExclusion Criteria:\n\n\u2022 previous history of breast cancer or other malignant tumors.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}